Table 4. Diagnostic performance of Tg, CT and CHFR1 for discriminating patients with PTC from PTC and MTC groups.
| Sensitivity % (95% CI) |
Specificity % (95% CI) |
Cut-off | AUC (95% CI) |
P-value | |
|---|---|---|---|---|---|
| MTC vs PTC | |||||
| CT | 21.62 [9.83–38.21] | 98.07 [95.13–99.47] | 7.74 pg/ml | 0.60 [0.50–0.66] | 0.7401 |
| Tg | 40.54 [24.75–57.90] | 74.80 [66.17–82.19] | 21.02 ng/ml | 0.58 [0.50–0.65] | 0.6459 |
| CFHR1 | 100.00 [90.75–100.00] | 85.08 [80.03–89.27] | 0.92 ng/ml | 0.93 [0.89–0.95] | <0.001 |
| CFHR1+CT | 21.62 [9.83–38.21] | 98.90 [96.07–99.87] | – | 0.91 [0.87–0.95] | <0.001 |
| FTC vs PTC | |||||
| CT | 33.33 [4.33–77.72] | 69.86 [63.14–75.99] | 1.01 pg/ml | 0.52 [0.45–0.58] | 0.3446 |
| Tg | 100.00 [54.07–100.00] | 30.08 [22.14–39.00] | 5.71 ng/ml | 0.65 [0.56–0.73] | 0.1074 |
| CFHR1 | 100.00 [54.07–100.00] | 11.69 [7.97–16.36] | 0.55 ng/ml | 0.56 [0.50–0.62] | 0.4496 |
| CFHR1+CT | 33.33 [4.33–77.72] | 71.58 [64.46–77.99] | – | 0.52 [0.45–0.60] | 0.3661 |
Note:
CI, confidence interval.